Received: 23 October 2019
Accepted: 7 April 2020
First Online: 22 April 2020
Ethics approval and consent to participate
: The trial has been approved by the Ethical Committee of the Medical Faculty of the University of Münster, Germany (reference number: 2016–620-f-S). Please see Appendix InternalRef removeda and Appendix InternalRef removedb for confirmations of the Ethical Committee in German and English language.Participation requires the provision of informed consent, and participants sign a written declaration of informed consent before they are enrolled in the trial. Please see Appendix InternalRef removeda and Appendix InternalRef removedb for the Informed Consent and patient information. Patients will be removed from the trial if he or she presents acute suicidal thoughts or loses the ability to understand the research process or the concept of informed consent during trial period.According to scientific conventions, the volunteers are fully informed about the study in written and verbal form and document their voluntary participation. Participation in the study can be discontinued at any time by participants without giving reasons and without any negative consequences for the patients regarding their treatment.To ensure anonymity, all questionnaire data are collected by assigning consecutive code numbers without name nor date of birth nor address. The data are archived in the research department and destroyed ten years after publication or if consent is withdrawn.
: The authors declare that they have no competing interests. Dr. Jobes receives grant support from the National Institute of Mental Health (NIMH) and the American Foundation for Suicide Prevention in the United States. He receives book royalties from Guilford Press and American Psychological Association Publications. He is a founder and co-owner of CAMS-care LLC, a training and consultation company.